21170 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE
#2OPTIMIZED EPICUTANEOUS VACCINATION
#3AVIRULENT LIVE BACTERIAL VACCINES CURED OF PLASMIDS CONTAINING ANTIMICROBIAL RESISTANCE GENES
#4METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE SYSTEM FUNCTION
#5Methods for Vaccinating against Salmonella Species
#6GENETICALLY MODIFIED BACTERIA FOR GENERATING VACCINES
#7COMPOSITIONS, KITS, METHODS, AND METHODS OF ADMINISTRATION RELATING TO EDWARDSIELLA PISCICIDA VACCINE AND/OR ANTIGEN DELIVERY VECTOR SYSTEMS
#8METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF INFECTIOUS AGENTS AND METAL CATIONS
#9STREPTOCOCCAL VACCINES AND METHODS FOR USE
#10IMMUNOGENIC GEL COMPOSITIONS
#11ADJUVANT FOR BACILLUS CALMETTE-GUERIN CANCER IMMUNOTHERAPY
#12BCG VACCINATIONS FOR PREVENTION OF COVID-19 AND OTHER INFECTIOUS DISEASES
#13EXTRACELLULAR VESICLE COMPRISING ANTIGENIC PROTEIN OR GENE ENCODING SAME PROTEIN, AND USES THEREOF
#14ENHANCED EXPRESSION VIA AUTOTRANSPORTERS
#15NOVEL VACCINES FOR TUBERCULOSIS
#16A CLINICAL ISOLATED AVIRULENT STRAIN PROTECTS AGAINST WILDTYPE VIRULENT CLOSTRIDIOIDES DIFFICILE INFECTION
#17IMMUNOGENIC COMPOSITIONS AND METHODS FOR REDUCING TRANSMISSION OF PATHOGENS
#18CHIMERIC ZIKA VIRUS ANTICANCER VACCINE OBTAINED THROUGH BREAST CANCER CELL PASSAGE
#19RECOMBINANT ATTENUATED SALMONELLA VACCINES (RASVS) AGAINST INFECTIONS BY AVIAN PATHOGENIC ESCHERICHIA COLI (APEC)
#20TREATMENT OF CANCER USING MRNA-MEDIATED VIRUS VACCINATION ANTIGENS DELIVERED BY ATTENUATED BACTERIA
#21BACILLUS SUBTILIS FLAGELLIN VARIANT AND USE THEREOF
#22INFECTIOUS PLASMODIUM SPOROZOITES GROWN IN VITRO
#23LIVE MYCOPLASMA GALLISEPTICUM VACCINES
#24Method for Preparing Outer Membrane Vesicles
#25COMPOSITIONS AND METHODS
#26ATTENUATED BORDETELLA BRONCHISEPTICA STRAINS, ORAL VACCINES CONTAINING THE ATTENUATED STRAINS, AND METHODS OF MAKING & USE THEREOF
#27Use of Bordetella Strains for the Treatment of Chronic Obstructive Pulmonary Disease
#28ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER
#29ATTENUATED MATURATION-DEFECTIVE CHLAMYDIA VACCINES
#30IMMUNOGENIC COMPOSITIONS
#31PREPARATION OF LIVE VACCINES
#32ANAPLASMA VACCINES AND METHODS OF USE THEREOF
#33METHODS AND COMPOSITIONS FOR MULTIVALENT VACCINES
#34NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS
#35A Novel Poultry Salmonella Vaccine and Diagnostic Methodology to Control Foodborne Salmonellosis
#36Listeria Variants and Methods of Use Thereof
#37CANCER THERAPY WITH LIVE ATTENUATED BACTERIA
#38BRUCELLA CANIS VACCINE FOR DOGS
#39Attenuated Bordetella Strains
#40COMPOSITIONS AND METHODS FOR REDUCING PARASITIC INFECTIONS
#41COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS
#42COMPOSITIONS INCORPORATING A GENETICALLY ATTENUATED PLASMODIUM WITH MODIFIED LIVER STAGE NUCLEAR PROTEIN (LINUP) AND RELATED METHODS
#43VACCINE COMPOSITIONS COMPRISING BRUCELLA STRAINS AND METHODS THEREOF
#44COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA
#45PROTECTIVE IMMUNITY ENHANCED ATTENUATED SALMONELLA VACCINE (PIESV) VECTOR SYSTEMS
#46Novel anti-cancer vaccine composition and a method of vaccination using the same
#47NOVEL CORONAVIRUS VACCINE BASED ON CONTROLLABLE SECRETORY EXPRESSION OF ATTENUATED SALMONELLA, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#48Recombinant Mycobacterium as an Immunotherapeutic Agent for the Second-Line Therapy of Bladder Carcinoma
#49COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES AGAINST CLASS I FUSION PROTEIN VIRUSES
#50OPTIMIZED EPICUTANEOUS VACCINATION
#51ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT COVID-19 INFECTION
#52Cancer therapy with live attenuated bacteria
#53ATTENUATED SALMONELLA GALLINARUM STRAIN AND USE THEREOF
#54AUTOTRANSPORTER SYSTEM
#55MULTIVALENT CHOLERA MULTIEPITOPE FUSION ANTIGEN (MEFA) AND METHODS OF USE
#56SALMONELLA VACCINE
#57Monovalent vaccine formulation and a method for preparation thereof
#58PREPARATION OF LIVE VACCINES
#59SLAM polynucleotides and polypeptides and uses thereof
#60MUTANT HERPESVIRUS AND VACCINE COMPOSITIONS
#61Infectious plasmodium sporozoites grown in vitro
#62NOVEL RECOMBINANT STRAIN OF MYCOBACTERIUM SMEGMATIS AND USE OF SAME
#63LYOPHILIZED AND STABILIZED LIVE ATTENUATED FORMULATED VACCINE AGAINST TULAREMIA
#64CHEMOVACCINATION AGAINST PLASMODIUM INFECTION WITH SELECTIVE PLASMEPSIN X INHIBITORS
#65Attenuating bacterial virulence by attenuating bacterial folate transport
#66BURKHOLDERIA VACCINES AND THERAPEUTICS
#67IMMUNOGENIC FORMULATION CONTAINING ONE OR MORE MODIFIED BCG STRAINS EXPRESSING A SARS-CoV-2 PROTEIN, USEFUL FOR PREVENTING, TREATING, OR ATTENUATING THE DEVELOPMENT OF COVID-19
#68IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII
#69METHOD FOR TREATING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME
#70GENETICALLY MODIFIED BACTERIA FOR GENERATING VACCINES
#71LIVE ATTENUATED STRAIN OF STREPTOCOCCUS PNEUMONIAE AND PHARMACEUTICAL COMPOSITIONS COMPRISING A LIVE ATTENUATED STRAIN OF S. PNEUMONIAE
#72STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
#73REPLICATION-DEFECTIVE VACCINES AND USES THEREOF
#74IMMUNOGENIC FORMULATION CONTAINING A MODIFIED BCG STRAIN EXPRESSING AN ANDESVIRUS PROTEIN (ANDV) USEFUL FOR PREVENTING AND TREATING HANTA-ANDV VIRUS INFECTIONS
#75HIGH DOSE SHIGELLA VACCINE PREPARATION
#76ENHANCED IMMUNOGENIC DNA/RNA COMPOSITIONS AND METHODS
#77Influenza vaccine, composition, and methods of use
#78METHOD FOR LYOPHILIZING LIVE VACCINE STRAINS OF FRANCISELLA TULARENSIS
#79LISTERIA-BASED COMPOSITIONS COMPRISING A PEPTIDE MINIGENE EXPRESSION SYSTEM AND METHODS OF USE THEREOF
#80A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG
#81VACCINATION AGAINST DIABETES, OBESITY AND COMPLICATIONS THEREOF
#82COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS
#83MODIFIED MYCOBACTERIUM BOVIS VACCINES
#84Attenuated Mycoplasma Bacteria
#85IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS
#86INFLUENZA VIRUS BACKBONE
#87Vaccine for falciparum malaria
#88Global gene regulators (GGR) as vaccine candidates against paratuberculosis
#89Modulation of replicative fitness by deoptimization of synonymous codons
#90COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC
#91THERAPEUTIC EFFICACY BY PULMONARY DELIVERY OF LIVE ATTENUATED MYCOBACTERIA
#92VIRULENT AEROMONAS VACCINES AND METHODS
#93Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals
#94Lyophilized Live Bordetella Vaccines
#95LIVE SELF-DESTRUCTING BACTERIAL ADJUVANTS TO ENHANCE INDUCTION OF IMMUNITY
#96Compositions for use as a prophylactic agent to those at risk of infection of tuberculosis, or as secondary agents for treating infected tuberculosis patients
#97WT1 TARGETING DNA VACCINE FOR COMBINATION THERAPY
#98A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE
#99IMMUNOGENIC GEL COMPOSITIONS
#100MONOVALENT VACCINE FORMULATION AND A METHOD FOR PREPARATION THEREOF
#101ATTENUATED SALMONELLA SYNTHESIZING ANTIGENS FOR VACCINATING AGAINST HELICOBACTER PYLORI
#102MODIFIED ADENOVIRUSES FOR INFECTIOUS DISEASE VACCINE DEVELOPMENT
#103Attenuated strain and vaccine
#104LIVE ATTENUATED LEISHMANIA PARASITE VACCINES WITH ENHANCED SAFETY CHARACTERISTICS
#105ORAL RESPIRATORY VACCINE
#106Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction
#107MYCOBACTERIAL COMPOSITIONS AND BIOMARKERS FOR USE IN TREATMENT AND MONITORING OF THERAPEUTIC RESPONSIVENESS
#108VACCINES AND RELATED METHODS FOR TREATMENT OF PSEUDOMONAS BACTERIAL INFECTIONS
#109USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT GESTATIONAL DIABETES MELLITUS
#110ATTENUATED NOCARDIA SERIOLAE AND CONSTRUCTION METHOD AND USE THEREOF
#111BORDETELLA STRAINS EXPRESSING SEROTYPE 3 FIMBRIAE
#112COMPOSITIONS AND METHODS FOR PRODUCING ENHANCED IMMUNE RESPONSES AND RAPID ANTIBODY PRODUCTION
#113VACCINE
#114LIVE ATTENUATED ORAL VACCINE AGAINST SHIGELLOSIS AND TYPHOID FEVER
#115COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF PRION DISEASE
#116VACCINE CONSTRUCTS AND USES THEREOF AGAINST STAPHYLOCOCCUS INFECTIONS
#117Modified vaccine strain for the treatment of brucellosis
#118Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy
#119Infectious sporozoites grown in vitro
#120MODIFIED STRAIN OF SALMONELLA ENTERICA TYPHI
#121Attenuating bacterial virulence by attenuating bacterial folate transport
#122PARASITE PURIFICATION
#123NOVEL LYSSA VIRUS PHOSPHOPROTEINS
#124Monovalent vaccine formulation and a method for preparation thereof
#125Recombinant Mycobacterium as an Immunotherapeutic Agent for the Treatment of Cancer
#126Live Attenuated Non-Transmissible Vaccines
#127Honeybee commensal vaccine against pathogenic
#128TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM
#129TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA
#130strains and vaccines having hyaC and nanP deletions
#131Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
#132Preparation of live vaccines
#133Process for the production of a DNA vaccine for cancer immunotherapy
#134Attenuated Bordetella Bronchiseptica Strains, Oral Vaccines Containing the Attenuated Strains, and Methods of Making & Use Thereof
#135SALMONELLA VACCINE FOR THE TREATMENT OF CORONAVIRUS
#136RECOMBINANT MUMPS VIRUS VACCINE EXPRESSING GENOTYPE G FUSION AND HEMAGGLUTININ-NEURAMINIDASE PROTEINS
#137Protective immunity enhanced vaccine (PIESV) against spp
#138Live self-destructing bacterial adjuvants to enhance induction of immunity
#139Controlled release vaccines and methods of treating diseases and disorders
#140SLAM polynucleotides and polypeptides and uses thereof
#141Pharmaceutical composition comprising attenuated strains and use thereof
#142virulence factor compositions
#143Method for preparing live attenuated vaccine by irradiation and live attenuated vaccine composition prepared by the same
#144Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#145STREPTOCOCCAL VACCINE FORMULATIONS AND USES THEREOF
#146Doubly attenuated late liver stage malaria parasites and related compositions and methods
#147Non-integrative listeria-based vaccine and method for inducing antitumor immune response
#148GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
#149Induction of protective immunity against antigens
#150Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines
#151Food safety vaccine to control and reduce in poultry
#152Vaccine for falciparum malaria
#153Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
#154Global gene regulators (GGR) as vaccine candidates against
#155Method for treating fibromyalgia and chronic fatigue syndrome
#156TUMOR IMMUNOTHERAPY COMPOSITION BASED ON ANTIGEN-PRESENTING CELLS ACTIVATED BY ATTENUATED LISTERIA MONOCYTOGENES, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#157Parasite vaccine
#158ALGAE COMPRISING THERAPEUTIC AND/OR NUTRITIONAL AGENTS
#159Method of manufacturing dual specific T-cells for use in cancer immunotherapy
#160Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, vaccines, and methods for making and using them
#161Double auxotrophic and uses thereof
#162METHOD OF REDUCING EGG CONTAMINATION
#163Attenuation system and use thereof
#164Methods of treating cancer using bacteria expressing c-di-AMP
#165NEW ATTENUATED STRAINS OF APICOMPLEXA AND THEIR USE AS ANTIGEN VECTORS FOR THE PREVENTION OF INFECTIOUS DISEASES
#166Optimized epicutaneous vaccination
#167Enhanced -enterotoxigenic multi-valent vaccine
#168Modified adenoviruses for cancer vaccines development
#169Ichthyophthirius multifiliis vaccine system
#170ENHANCEMENT OF PATHOGEN IMMUNOGENICITY
#171Modified vaccine strain for the treatment of brucellosis
#172VEGFR-2 TARGETING DNA VACCINE FOR COMBINATION THERAPY
#173Vaccination against diabetes, obesity and complications thereof
#174Fungal immunogens and related materials and methods
#175Immunogenic compositions comprising
#176Method for lyophilizing live vaccine strains of
#177Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
#178Live attenuated oral vaccine against ETEC and typhoid fever
#179Edible vaccines expressed in yeast for preventing and treating infectious diseases in animals and human
#180Mutant strains and methods of use
#181Campylobacter immunogenic compositions and uses thereof
#182strains expressing serotype 3 fimbriae
#183Fungal immunogens and related materials and methods
#184Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes
#185Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#186Pharmaceutical composition comprising attenuated strains and use thereof
#187BACTERIAL VACCINE
#188Bacterial protein compositions and uses thereof
#189ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI
#190Live attenuated cholera vaccine with probiotic properties
#191Biofilm matrix-boosted vaccine
#192Modulation of replicative fitness by deoptimization of synonymous codons
#193virulence factor compositions
#194Modified strain of Typhi
#195Bordetella vaccine
#196Live attenuated bacterial strain and its use as a vaccine
#197Live attenuated vaccines
#198Bacterial vaccine components and uses thereof
#199Targeted gene disruption methods and immunogenic compositions
#200Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer
#201Global gene regulators (GGR) as vaccine candidates against paratuberculosis
#202Attenuated strains
#203Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
#204Fungal immunogens and related materials and methods
#205Bacterial vaccine components and uses thereof
#206Live attenuated parasitic vaccine
#207GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
#208ATTENUATED FISH VACCINE FOLLOWING CULTURE IN IRON LIMITED MEDIA
#209Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#210Infectious plasmodium sporozoites grown in vitro
#211Mesothelin vaccines and model systems
#212Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
#213PD-L1 targeting DNA vaccine for cancer immunotherapy
#214VEGFR-2 targeting immunotherapy approach
#215VACCINES, COMPOSITIONS AND METHODS FOR USE THEREOF TO PREVENT OR REDUCE SEVERITY OF CHOLERA
#216Virulent vaccines and methods
#217LIVE BACTERIAL VACCINES RESISTANT TO CARBON DIOXIDE (CO2), ACIDIC PH AND/OR OSMOLARITY FOR VIRAL INFECTION PROPHYLAXIS OR TREATMENT
#218Attenuated strain of pseudomonas as a vaccine for pseudomonas infection
#219Vaccine for falciparum malaria
#220Food safety vaccine to control and reduce campylobacter in poultry
#221Attenuated vaccines to protect against tick-borne species infections
#222Induction of protective immunity against antigens
#223Oral vaccine against ruminant respiratory disease comprising polyvinylpyrrolidone
#224PERSONALIZED DELIVERY VECTOR-BASED IMMUNOTHERAPY AND USES THEREOF
#225Doubly attenuated late liver stage malaria parasites and related compositions and methods
#226Method for reducing skatole and/or indole in animals
#227Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#228Antibodies that modulate immunity to drug resistant and latent MTB infections
#229Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes P8 protein, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same
#230Compositions and methods for treatment of cancer using bacteria
#231Edible vaccines expressed in yeast for preventing and treating infectious diseases in animals and humans
#232Fungal vaccine compositions and methods of use thereof
#233Immune modulator and vaccine composition containing the same
#234compositions
#235Safe potent single platform vaccine against Tier 1 select agents and other pathogens
#236RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF PRODUCING THE SAME
#237Vaccine constructs and uses thereof against infections
#238Immunomodulation after locoregional anti-tumoral treatment
#239Microparticulated Vaccines for the Oral or Nasal Vaccination and Boostering of Animals Including Fish
#240Method of reducing egg contamination
#241Protective anti-ZIKV vaccine without inducing cross-reactions with dengue
#242Process for the production of a DNA vaccine for cancer immunotherapy
#243Antibody to cytolethal distending toxin of Campylobacter jejuni
#244Attenuated strains
#245Vaccines for prevention and treatment of tuberculosis
#246Live attenuated vaccine and method of using the same
#247Controlled release vaccines and methods for treating diseases and disorders
#248Immunogenic compositions comprising
#249Compositions comprising angiogenic factors and methods of use thereof
#250SLAM polynucleotides and polypeptides and uses thereof
#251Compositions and methods of preparing
#252METHOD OF MAKING A VACCINE
#253Method of making a vaccine
#254Attenuated bacterium
#255Method for treating fibromyalgia and chronic fatigue syndrome
#256Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes
#257Campylobacter immunogenic compositions and uses thereof
#258RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF USING THE SAME IN CANCER IMMUNOTHERAPY
#259Methods of treating cancer using bacteria expressing c-di-AMP
#260Live bacterial vectors for prophylaxis or treatment
#261Virulence attenuated bacteria for treatment of malignant solid tumors
#262METHODS AND COMPOSITIONS USING LISTERIA FOR ENHANCING IMMUNOGENICITY BY PRIME BOOST
#263DNA vaccine for use in pancreatic cancer patients
#264Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
#265ATTENUATED MANNHEIMIA HAEMOLYTICA STRAINS
#266Naturally-occurring CpG oligonucleotide compositions and therapeutic applications thereof
#267GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
#268Vaccination against diabetes, obesity and complications thereof
#269Attenuated vaccines to protect against tick-borne species infections
#270LISTERIA-BASED IMMUNOTHERAPY AND METHODS OF USE THEREOF
#271Prevention of pertussis using adenylate cyclase deficient Bordetella strains
#272Method of manufacturing dual-specific T-cells for use in cancer immunotherapy
#273Bacterial RNAs as vaccine adjuvants
#274MANUFACTURING DEVICE AND METHOD OF AN IMMUNOTHERAPEUTIC FORMULATION COMPRISING A RECOMBINANT LISTERIA STRAIN
#275Method to enhance immunogenicity of live typhoid vaccines and carriers
#276Compositions and methods for treatment of bacterial infections
#277Bacterial vaccine components and uses thereof
#278ENGINEERED LISTERIA AND METHODS OF USE THEREOF
#279Live attenuated heterologous vaccine for
#280Live attenuated oral vaccine against shigellosis and typhoid fever
#281Modulation of replicative fitness by deoptimization of synonymous codons
#282Bacillus based delivery system and methods of use
#283VEGFR-2 targeting DNA vaccine for combination therapy
#284Transfection vector for pathogenic amoebae and uses thereof
#285Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines
#286elongation factor-1 alpha recombinant immunogenic compositions which induce active protective immunity against avian coccidiosis
#287Recombinant as an immunotherapeutic agent for the treatment of cancer
#288Concomitant dengue and yellow fever vaccination
#289Methods and compositions to prevent or treat bacterial infections
#290COMBINATION OF A PD-1 ANTAGONIST AND A LISTERIA-BASED VACCINE FOR TREATING PROSTATE CANCER
#291Immunogenic compositions against tuberculosis
#292Oral cancer vaccine
#293Infectious plasmodium sporozoites grown in vitro
#294NOVEL CMV PP65 TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY
#295Combination Therapies With Recombinant Listeria Strains
#296Interferon-β production modulating strains and methods for using same
#297Recombinant probiotic bacteria
#298Vaccine composition for treating or preventing shigellosis
#299Antibodies that modulate immunity to drug resistant and latent MTB infections
#300Fungal immunogens and related materials and methods